| scholarly article | Q13442814 |
| P50 | author | Godfrey D. Pearlson | Q21114976 |
| P2093 | author name string | Buchanan RW | |
| Barta PE | |||
| Vladar K | |||
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | schizophrenia | Q41112 |
| P1104 | number of pages | 7 | |
| P304 | page(s) | 1049-1055 | |
| P577 | publication date | 1998-08-01 | |
| P1433 | published in | American Journal of Psychiatry | Q1935368 |
| P1476 | title | Structural evaluation of the prefrontal cortex in schizophrenia | |
| P478 | volume | 155 |
| Q36013286 | A comprehensive assessment of gray and white matter volumes and their relationship to outcome and severity in schizophrenia |
| Q99604509 | A potential biomarker for treatment stratification in psychosis: evaluation of an [18F] FDOPA PET imaging approach |
| Q24657354 | A review of MRI findings in schizophrenia |
| Q24288871 | A systematic examination of brain volumetric abnormalities in recent-onset schizophrenia using voxel-based, surface-based and region-of-interest-based morphometric analyses |
| Q34129991 | Adjunctive risperidone for partially responsive people with schizophrenia treated with clozapine |
| Q37252320 | Age-associated differences in cognitive performance in older community dwelling schizophrenia patients: differential sensitivity of clinical neuropsychological and experimental information processing tests |
| Q49110783 | Altered myelination of the hippocampal formation in subjects with schizophrenia and bipolar disorder |
| Q28250481 | An association screen of myelin-related genes implicates the chromosome 22q11 PIK4CA gene in schizophrenia |
| Q48542669 | Anterior cingulate subregion volumes and executive function in bipolar disorder |
| Q38360887 | Antipsychotic drug treatment induces differential gene expression in the rat cortex. |
| Q30386608 | Antipsychotic drugs: comparison in animal models of efficacy, neurotransmitter regulation, and neuroprotection |
| Q31120592 | Are brain structural abnormalities useful as endophenotypes in schizophrenia? |
| Q52152130 | Association of serum VEGF levels with prefrontal cortex volume in schizophrenia. |
| Q48953087 | Association of white matter deficits with clinical symptoms in antipsychotic-naive first-episode schizophrenia: an optimized VBM study using 3T. |
| Q98172194 | Atypical response inhibition and error processing in 22q11.2 Deletion Syndrome and schizophrenia: Towards neuromarkers of disease progression and risk |
| Q33666136 | Automated MRI parcellation of the frontal lobe |
| Q51886464 | Automated MRI parcellation study of regional volume and thickness of prefrontal cortex (PFC) in antipsychotic-naïve schizophrenia. |
| Q30784001 | Boundaries of schizophrenia |
| Q30984127 | Brain glucose metabolism in the early and specific diagnosis of Alzheimer's disease. FDG-PET studies in MCI and AD. |
| Q30582499 | Brain gray and white matter transverse relaxation time in schizophrenia |
| Q47266996 | Brain morphology in nonsyndromic unicoronal craniosynostosis. |
| Q36085553 | Brain volume and shape in infants with deformational plagiocephaly |
| Q48752188 | Brain-derived neurotrophic factor and neurotrophin 3 in schizophrenic psychoses |
| Q30704172 | BrainImageJ: a Java-based framework for interoperability in neuroscience, with specific application to neuroimaging |
| Q51969760 | Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis. |
| Q47432960 | Central nervous system phenotypes in craniosynostosis |
| Q48865822 | Cerebral gray and white matter reductions and clinical correlates in patients with early onset schizophrenia. |
| Q36414518 | Clinical trials for antipsychotic drugs: design conventions, dilemmas and innovations. |
| Q44603419 | Clozapine but not haloperidol Re-establishes normal task-activated rCBF patterns in schizophrenia within the anterior cingulate cortex |
| Q33383369 | Combining gene expression, demographic and clinical data in modeling disease: a case study of bipolar disorder and schizophrenia |
| Q36826795 | Comorbidity implications in brain disease: neuronal substrates of symptom profiles |
| Q30474963 | Contribution of nonprimate animal models in understanding the etiology of schizophrenia |
| Q36976526 | Convergent and divergent functional connectivity patterns in schizophrenia and depression |
| Q33288189 | Correlations between Diffusion Tensor Imaging (DTI) and Magnetic Resonance Spectroscopy (1H MRS) in schizophrenic patients and normal controls |
| Q35818882 | Cortical structural abnormalities in deficit versus nondeficit schizophrenia |
| Q38649630 | Cost-effectiveness of 3-month paliperidone therapy for chronic schizophrenia in the Netherlands. |
| Q48227957 | Decreased volume and increased asymmetry of the anterior limb of the internal capsule in patients with schizophrenia |
| Q39662863 | Detecting Anatomical Landmarks for Fast Alzheimer's Disease Diagnosis |
| Q48874492 | Differential contributions of prefrontal and temporolimbic pathology to mechanisms of psychosis |
| Q54785591 | Differential expression and regulatory roles of FABP5 and FABP7 in oligodendrocyte lineage cells. |
| Q34502240 | Differentiation of oligodendrocyte precursors is impaired in the prefrontal cortex in schizophrenia |
| Q30770466 | Diffusion tensor imaging in normal aging and neuropsychiatric disorders |
| Q57437366 | Dihydropyrimidinase-related protein 2 (DRP-2) gene and association to deficit and nondeficit schizophrenia |
| Q30491249 | Downregulation of oligodendrocyte transcripts is associated with impaired prefrontal cortex function in rats |
| Q46273440 | Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study |
| Q48772850 | Electron microscopy of oligodendroglia in severe mental illness. |
| Q73553135 | Evidence for a compromised dorsolateral prefrontal cortical parallel circuit in schizophrenia |
| Q47290673 | Frontal and temporal volume size of grey and white matter in patients with schizophrenia: an MRI parcellation study |
| Q30579702 | Frontal lobe psychopathology: mania, depression, confabulation, catatonia, perseveration, obsessive compulsions, and schizophrenia |
| Q37455994 | Functional and anatomical connectivity abnormalities in left inferior frontal gyrus in schizophrenia. |
| Q43883661 | Geissoschizine methyl ether, an alkaloid from the Uncaria hook, improves remyelination after cuprizone-induced demyelination in medial prefrontal cortex of adult mice |
| Q49132886 | Genetic study of the myelin oligodendrocyte glycoprotein (MOG) gene in schizophrenia. |
| Q42544021 | Glutamatergic antipsychotic drugs: a new dawn in the treatment of schizophrenia? |
| Q41828924 | Gray matter volume reduction in rostral middle frontal gyrus in patients with chronic schizophrenia |
| Q48227969 | Gyrification abnormalities in childhood- and adolescent-onset schizophrenia. |
| Q91442157 | Heterogeneity and efficacy of antipsychotic treatment for schizophrenia with or without treatment resistance: a meta-analysis |
| Q48630287 | Increased hippocampal volume in schizophrenics' parents with ancestral history of schizophrenia |
| Q40531131 | Inhibition of system A-mediated glycine transport in cortical synaptosomes by therapeutic concentrations of clozapine: implications for mechanisms of action |
| Q48216075 | Investigation of frontal lobe subregions in first-episode schizophrenia |
| Q44759703 | Issues that may determine the outcome of antipsychotic trials: industry sponsorship and extrapyramidal side effect |
| Q35691214 | MR imaging anatomy in neurodegeneration: a robust volumetric parcellation method of the frontal lobe gyri with quantitative validation in patients with dementia |
| Q48449775 | MRI parcellation of the frontal lobe in boys with attention deficit hyperactivity disorder or Tourette syndrome |
| Q37308191 | Manual MRI parcellation of the frontal lobe |
| Q48245371 | Measurement of the orbitofrontal cortex: a validation study of a new method |
| Q37358875 | Metabotropic glutamate receptor 2 and 3 gene expression in the human prefrontal cortex and mesencephalon in schizophrenia. |
| Q44407127 | Micromolar Brain Levels of Kynurenic Acid are Associated with a Disruption of Auditory Sensory Gating in the Rat |
| Q48571124 | Morphology of the ventral frontal cortex in schizophrenia: relationship with social dysfunction |
| Q47903915 | Multimodal neuroimaging studies and neurodevelopment and neurodegeneration hypotheses of schizophrenia |
| Q52168810 | Neural correlates of memory organization deficits in schizophrenia. A single photon emission computed tomography study with 99mTc-ethyl-cysteinate dimer during a verbal learning task. |
| Q34399238 | Neural network models of schizophrenia |
| Q30698640 | Neuroanatomy and neurophysiology in schizophrenia |
| Q30925033 | Neurodevelopmental hypothesis in schizophrenia |
| Q30621004 | New insights on the neuroanatomy of schizophrenia |
| Q30712168 | Newer techniques in magnetic resonance imaging and their potential for neuropsychiatric research |
| Q51943076 | Oligodendroglial density in the prefrontal cortex in schizophrenia and mood disorders: a study from the Stanley Neuropathology Consortium. |
| Q51822628 | Optimized voxel brain morphometry: association between brain volumes and the response to atypical antipsychotics. |
| Q36806115 | Orbitofrontal cortex, emotional decision-making and response to cognitive behavioural therapy for psychosis |
| Q37146700 | Overlapping and distinct gray and white matter abnormalities in schizophrenia and bipolar I disorder |
| Q30760640 | Pathogenesis of schizophrenia: Part I. Symptomatology, cognitive characteristics and brain morphology |
| Q28743566 | Patterns of differences in brain morphology in humans as compared to extant apes |
| Q36715888 | Pharmacological treatment of negative symptoms of schizophrenia: therapeutic opportunity or cul-de-sac? |
| Q38220045 | Pharmacological treatment of schizophrenia resistant to first-line treatment: a critical systematic review and meta-analysis |
| Q28751205 | Phenotypic integration of neurocranium and brain |
| Q45057752 | Predictors of response in a sample of treatment-resistant psychotic patients on clozapine |
| Q35632540 | Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia |
| Q33754429 | Prefrontal cortex, negative symptoms, and schizophrenia: an MRI study |
| Q36054203 | Prefrontal deviations in function but not volume are putative endophenotypes for schizophrenia |
| Q49061779 | Prenatal exposure to maternal infection alters cytokine expression in the placenta, amniotic fluid, and fetal brain |
| Q51431445 | Presynaptic and postsynaptic dopaminergic binding densities in the nigrostriatal and mesocortical systems in early Parkinson's disease: a double-tracer positron emission tomography study. |
| Q47673850 | Presynaptic proteins in the prefrontal cortex of patients with schizophrenia and rats with abnormal prefrontal development |
| Q44112647 | Proton magnetic resonance spectroscopy of the inferior frontal gyrus and thalamus and its relationship to verbal learning task performance in patients with schizophrenia: a preliminary report |
| Q34995855 | Quality of life in schizophrenia: a review of the literature from 1995 to 2000. |
| Q30788797 | Quantification of frontal and temporal lobe brain-imaging findings in schizophrenia: a meta-analysis |
| Q51972946 | Quetiapine facilitates oligodendrocyte development and prevents mice from myelin breakdown and behavioral changes. |
| Q52026405 | Reduced anterior cingulate gyrus volume correlates with executive dysfunction in men with first-episode schizophrenia. |
| Q40765182 | Reduced fronto-striatal white matter integrity in schizophrenia patients and unaffected siblings: a DTI study |
| Q48375068 | Reduced gray matter volume of Brodmann's Area 45 is associated with severe psychotic symptoms in patients with schizophrenia |
| Q60644883 | Reduced number of mediodorsal and anterior thalamic neurons in schizophrenia |
| Q48630254 | Regional changes in brain gray and white matter in patients with schizophrenia demonstrated with voxel-based analysis of MRI. |
| Q48907265 | Regional cortical white matter reductions in velocardiofacial syndrome: a volumetric MRI analysis |
| Q47234227 | Regional frontal abnormalities in schizophrenia: a quantitative gray matter volume and cortical surface size study. |
| Q48550977 | Regional prefrontal gray and white matter abnormalities in bipolar disorder |
| Q48492733 | Relationship between exploratory eye movements and brain morphology in schizophrenia spectrum patients: voxel-based morphometry of three-dimensional magnetic resonance imaging |
| Q47281967 | Relationship of brain and skull in pre- and postoperative sagittal synostosis |
| Q37472068 | Response suppression deficits in treatment-naïve first-episode patients with schizophrenia, psychotic bipolar disorder and psychotic major depression |
| Q37638930 | Review: The biological basis of antipsychotic response in schizophrenia |
| Q48336037 | Searching for a structural endophenotype in psychosis using computational morphometry |
| Q48188183 | Sex-dependent effects of schizophrenia: an MRI study of gyral folding, and cortical and white matter volume. |
| Q34108518 | Should the treatment of schizophrenia include old antipsychotic drugs? |
| Q33371452 | Social cognition in schizophrenia: a review of face processing. |
| Q46411318 | Social interaction deficits caused by chronic phencyclidine administration are reversed by oxytocin |
| Q37362275 | Source-based morphometry: the use of independent component analysis to identify gray matter differences with application to schizophrenia |
| Q33628565 | Structural abnormalities in gyri of the prefrontal cortex in individuals with schizophrenia and their unaffected siblings |
| Q30581145 | Structural brain imaging in schizophrenia: a selective review |
| Q24802626 | Survey on schizophrenia treatment in Mexico: perception and antipsychotic prescription patterns |
| Q33838916 | Switching antipsychotic therapies |
| Q34031938 | The DTNBP1 (dysbindin-1) gene variant rs2619522 is associated with variation of hippocampal and prefrontal grey matter volumes in humans. |
| Q36633604 | The anatomy of co-morbid neuropsychiatric disorders based on cortico-limbic synaptic interactions |
| Q37418017 | The impact of the genome-wide supported variant in the cyclin M2 gene on gray matter morphology in schizophrenia |
| Q24561923 | The role of the hippocampus in the pathophysiology of major depression |
| Q36585021 | The timing of neurodevelopmental abnormality in schizophrenia: an integrative review of the neuroimaging literature. |
| Q48169998 | Total length of nerve fibers in prefrontal and global white matter of chronic schizophrenics |
| Q34108164 | Treatment of negative and cognitive symptoms |
| Q24648426 | Uncinate fasciculus findings in schizophrenia: a magnetic resonance diffusion tensor imaging study |
| Q30769853 | Volumes of association thalamic nuclei in schizophrenia: a postmortem study |
| Q30659517 | Volumetric analysis of the pre-frontal regions: findings in aging and schizophrenia. |
| Q36169035 | White matter abnormalities and animal models examining a putative role of altered white matter in schizophrenia |
| Q37159928 | White matter alterations in deficit schizophrenia. |
| Q43833363 | Working memory deficits in schizophrenia are not necessarily specific or associated with MRI-based estimates of area 46 volumes. |
| Q34640811 | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance |
| Q33223628 | World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, Part 1: acute treatment of schizophrenia |
| Q57422543 | fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder |
Search more.